Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03967223 |
|---|---|
| Brief Title: | Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors (IGNYTE-ESO) |
| First Submitted : | May 10, 2019 |
| First Submitted that Met QC Criteria : | May 28, 2019 |
| First Posted : | May 30, 2019 |
| Last Update Submitted that Met QC Criteria : | April 24, 2024 |
| Last Update Posted : | April 25, 2024 |